Debabrata Roy

1.2k total citations
42 papers, 377 citations indexed

About

Debabrata Roy is a scholar working on Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Debabrata Roy has authored 42 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Infectious Diseases. Recurrent topics in Debabrata Roy's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Debabrata Roy is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Debabrata Roy collaborates with scholars based in United Kingdom, India and United States. Debabrata Roy's co-authors include Waljit S. Dhillo, James Gardiner, Kevin G. Murphy, Mohammad A. Ghatei, Vicki Osborne, Alison Evans, Saad Shakir, Samantha Lane, Gavin A. Bewick and Peter J. Friend and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Debabrata Roy

38 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debabrata Roy United Kingdom 11 95 59 54 48 46 42 377
Rosário Maldonado Spain 11 128 1.3× 42 0.7× 10 0.2× 25 0.5× 37 0.8× 20 353
Niamh Phelan Ireland 11 129 1.4× 74 1.3× 21 0.4× 17 0.4× 18 0.4× 26 515
Eka Melson United Kingdom 11 67 0.7× 68 1.2× 21 0.4× 74 1.5× 19 0.4× 35 441
V. Robert France 9 69 0.7× 115 1.9× 10 0.2× 89 1.9× 27 0.6× 14 459
Seyed‐Amir Tabatabaeizadeh Iran 11 64 0.7× 91 1.5× 54 1.0× 29 0.6× 8 0.2× 16 502
Debmalya Sanyal India 11 56 0.6× 89 1.5× 11 0.2× 114 2.4× 26 0.6× 64 662
Nazia Raja‐Khan United States 12 238 2.5× 96 1.6× 46 0.9× 61 1.3× 11 0.2× 23 743
Nigel W. Brown United Kingdom 15 78 0.8× 51 0.9× 47 0.9× 92 1.9× 17 0.4× 25 550
Emmanuel Kokori Nigeria 9 57 0.6× 39 0.7× 22 0.4× 56 1.2× 6 0.1× 97 323
G. Veyrac France 11 33 0.3× 28 0.5× 44 0.8× 32 0.7× 15 0.3× 41 531

Countries citing papers authored by Debabrata Roy

Since Specialization
Citations

This map shows the geographic impact of Debabrata Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debabrata Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debabrata Roy more than expected).

Fields of papers citing papers by Debabrata Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debabrata Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debabrata Roy. The network helps show where Debabrata Roy may publish in the future.

Co-authorship network of co-authors of Debabrata Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Debabrata Roy. A scholar is included among the top collaborators of Debabrata Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debabrata Roy. Debabrata Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Debabrata, et al.. (2025). Safety and effectiveness of the anti‐amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective. British Journal of Clinical Pharmacology. 91(5). 1352–1360. 3 indexed citations
2.
Evans, Alison, et al.. (2025). Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study. BMJ Open. 15(5). e093366–e093366. 1 indexed citations
3.
4.
5.
Hunsel, Florence van, Nicoletta Luxi, Nicolas H. Thurin, et al.. (2024). Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study. Vaccine. 42(9). 2357–2369. 10 indexed citations
6.
7.
Biswas, N., et al.. (2023). Differential expression of TLR4 in patients of coronary artery disease with and without traditional cardiovascular risk factors. European Heart Journal. 44(Supplement_1). 1 indexed citations
8.
Sethi, Yashendra, et al.. (2022). Psychological Assessment of Family Caregivers of Patients With COVID-19 in the United States of America and India. Cureus. 14(9). e29267–e29267. 2 indexed citations
9.
Kaplan, Sigal, Monica L. Bertoia, Florence T. Wang, et al.. (2021). Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States. Contraception. 105. 26–32. 2 indexed citations
10.
11.
Evans, Alison, et al.. (2021). A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events. Frontiers in Pharmacology. 12. 726141–726141. 6 indexed citations
12.
Osborne, Vicki, et al.. (2020). Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment. Drug Safety. 43(7). 645–656. 43 indexed citations
13.
Osborne, Vicki, et al.. (2020). Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management. BMJ evidence-based medicine. 25(6). 199–205. 7 indexed citations
14.
Ray, Saumitra, Debabrata Roy, Kajal Ganguly, et al.. (2017). Exercise and eating habits among urban adolescents: a cross-sectional study in Kolkata, India. BMC Public Health. 17(1). 468–468. 31 indexed citations
15.
McGowan, Barbara, James Minnion, Kevin G. Murphy, et al.. (2014). Relaxin-3 stimulates the neuro-endocrine stress axis via corticotrophin-releasing hormone. Journal of Endocrinology. 221(2). 337–346. 32 indexed citations
16.
Mukhopadhyay, Madhumita, et al.. (2011). Comparative Study Between Omentopexy and Omental Plugging in Treatment of Giant Peptic Perforation. Indian Journal of Surgery. 73(5). 341–345. 13 indexed citations
17.
McGowan, Barbara, James Minnion, Kevin G. Murphy, et al.. (2010). Central and peripheral administration of human relaxin‐2 to adult male rats inhibits food intake. Diabetes Obesity and Metabolism. 12(12). 1090–1096. 16 indexed citations
18.
Gardiner, James, Kylie Beale, Debabrata Roy, et al.. (2010). Cerebellin1 is a novel orexigenic peptide. Diabetes Obesity and Metabolism. 12(10). 883–890. 7 indexed citations
19.
Roy, Debabrata, et al.. (2008). Alemtuzumab Induction and Steroid-Free Maintenance Immunosuppression in Pancreas Transplantation. American Journal of Transplantation. 8(10). 2126–2131. 35 indexed citations
20.
Roy, Debabrata, et al.. (2007). Thromboelastography directed anticoagulation in pancreas transplantation. Transplant International. 20. 78–78. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosário Maldonado Breakdown of academic impact, for papers by Niamh Phelan Breakdown of academic impact, for papers by Eka Melson Breakdown of academic impact, for papers by V. Robert Breakdown of academic impact, for papers by Seyed‐Amir Tabatabaeizadeh Breakdown of academic impact, for papers by Debmalya Sanyal Breakdown of academic impact, for papers by Nazia Raja‐Khan Breakdown of academic impact, for papers by Nigel W. Brown Breakdown of academic impact, for papers by Emmanuel Kokori Breakdown of academic impact, for papers by G. Veyrac
Rankless by CCL
2026